Soft earnings didn't appear to concern IVD Medical Holding Limited's (HKG:1931) shareholders over the last week. Our analysis suggests that while the profits are soft, the foundations of the business are strong.
View our latest analysis for IVD Medical Holding
SEHK:1931 Earnings and Revenue History September 23rd 2022
How Do Unusual Items Influence Profit?
Importantly, our data indicates that IVD Medical Holding's profit was reduced by CN¥29m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. If IVD Medical Holding doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of IVD Medical Holding.
Our Take On IVD Medical Holding's Profit Performance
Because unusual items detracted from IVD Medical Holding's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Based on this observation, we consider it likely that IVD Medical Holding's statutory profit actually understates its earnings potential! Unfortunately, though, its earnings per share actually fell back over the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about IVD Medical Holding as a business, it's important to be aware of any risks it's facing. Be aware that IVD Medical Holding is showing 2 warning signs in our investment analysis and 1 of those makes us a bit uncomfortable...
This note has only looked at a single factor that sheds light on the nature of IVD Medical Holding's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
疲软的收益似乎并不令人担忧IVD医疗控股有限公司(HKG:1931)过去一周的股东人数。我们的分析表明,尽管利润疲软,但业务的基础是强大的。
查看我们对IVD Medical Holding的最新分析
联交所:1931年盈利及收入历史2022年9月23日
不寻常的项目如何影响利润?
重要的是,我们的数据显示,由于异常项目,IVD Medical Holding去年的利润减少了2900万元人民币。看到不寻常的项目让公司损失利润从来都不是件好事,但从好的方面来看,情况可能很快就会改善。当我们分析全球绝大多数上市公司时,我们发现重大的不寻常项目往往不会重复。毕竟,这正是会计术语所暗示的。如果IVD Medical Holding没有看到这些不寻常的支出再次出现,那么在其他条件相同的情况下,我们预计来年其利润将会增加。
注:我们总是建议投资者检查资产负债表的实力。点击此处查看我们对IVD Medical Holding的资产负债表分析。
我们对IVD医疗控股公司利润表现的看法
由于不寻常的项目减损了IVD Medical Holding去年的收益,你可以辩称,我们可以预期本季度的业绩会有所改善。基于这一观察,我们认为IVD Medical Holding的法定利润实际上很可能低估了其盈利潜力!然而,不幸的是,它的每股收益实际上在去年有所回落。本文的目的是评估我们可以在多大程度上依赖法定收益来反映公司的潜力,但还有很多东西需要考虑。如果你想更多地了解IVD Medical Holding作为一项业务,了解它面临的任何风险是很重要的。请注意,IVD医疗控股公司正在展示我们的投资分析中的2个警告信号其中一件让我们有点不舒服……
这份报告只关注了一个因素,它揭示了IVD Medical Holding的利润性质。但如果你有能力将注意力集中在细枝末节上,总会有更多的东西需要发现。一些人认为,高股本回报率是高质量企业的良好标志。所以你可能想看看这个免费拥有高股本回报率的公司的集合,或内部人士正在购买的这份股票清单。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。